Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Therapeutics
The 2025-2030 World Outlook for Lung Cancer Therapeutics This study covers the world outlook for lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries This study covers the world outlook for basal cell carcinoma surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Products
The 2025-2030 World Outlook for Cancer Supportive Care Products This study covers the world outlook for cancer supportive care products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Blood Cancers
The 2025-2030 World Outlook for Blood Cancers This study covers the world outlook for blood cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries This study covers the world outlook for thoracotomy lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics This study covers the world outlook for chemotherapy and other multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs
The 2025-2030 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs This study covers the world outlook for chemotherapy-induced nausea and vomiting drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Gastroesophageal Cancers
The 2025-2030 World Outlook for Gastroesophageal Cancers This study covers the world outlook for gastroesophageal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Metastatic Bone Disease Medications
The 2025-2030 World Outlook for Metastatic Bone Disease Medications This study covers the world outlook for metastatic bone disease medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics This study covers the world outlook for uterine cancer therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics This study covers the world outlook for uterine cancer treatments and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Uterine Sarcoma Therapeutics and Diagnostics
The 2025-2030 World Outlook for Uterine Sarcoma Therapeutics and Diagnostics This study covers the world outlook for uterine sarcoma therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics This study covers the world outlook for ovarian cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Drugs
The 2025-2030 World Outlook for Gastric Cancer Drugs This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Inorganic Capsule and Vascular Material Systems
The 2025-2030 World Outlook for Inorganic Capsule and Vascular Material Systems This study covers the world outlook for inorganic capsule and vascular material systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Liquid Biopsies
The 2025-2030 World Outlook for Liquid Biopsies This study covers the world outlook for liquid biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Immune Checkpoint Inhibitors
The 2025-2030 World Outlook for Immune Checkpoint Inhibitors This study covers the world outlook for immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Silent Cancer Therapeutics
The 2025-2030 World Outlook for Silent Cancer Therapeutics This study covers the world outlook for silent cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More